Carboplatin/etoposide/osimertinibLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1958卷 / 1期

关键词：

D O I：

10.1007/s40278-023-39804-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：130 / 130

相关论文

共 50 条

[21] OsimertinibLack of efficacy: case report
Reactions Weekly, 2022, 1894 (1) : 260 - 260
[22] OsimertinibLack of efficacy: case report
Reactions Weekly, 2023, 1944 (1) : 462 - 462
[23] OsimertinibLack of efficacy: case report
Reactions Weekly, 2024, 2032 (1) : 374 - 374
[24] OsimertinibLack of efficacy: case report
Reactions Weekly, 2025, 2053 (1) : 292 - 292
[25] OsimertinibLack of efficacy: case report
Reactions Weekly, 2023, 1964 (1) : 345 - 345
[26] OsimertinibLack of efficacy: case report
Reactions Weekly, 2022, 1887 (1) : 551 - 551
[27] Carboplatin/etoposide/toripalimabLack of efficacy and hypophysitis: case report
Reactions Weekly, 2023, 1957 (1) : 119 - 119
[28] Gefitinib/osimertinibLack of efficacy: case report
Reactions Weekly, 2022, 1914 (1) : 232 - 232
[29] Catequentinib/osimertinibLack of efficacy: case report
Reactions Weekly, 2023, 1970 (1) : 88 - 88
[30] Catequentinib/osimertinibLack of efficacy: case report
Reactions Weekly, 2023, 1946 (1) : 150 - 150

← 1 2 3 4 5 →